The assessment of future RSV immunizations: How to protect all infants?

Louis Bont; Catherine Weil Olivier; Egbert Herting; Susanna Esposito; Jose Antonio Navarro Alonso; Federico Lega; Silke Mader; Ichiro Morioka; Kunling Shen; George A. Syrogiannopoulos; Saul N. Faust; Elena Bozzola

doi:10.3389/fped.2022.981741

The assessment of future RSV immunizations: How to protect all infants?

Louis Bont, Catherine Weil Olivier, Egbert Herting, Susanna Esposito, Jose Antonio Navarro Alonso, Federico Lega, Silke Mader, Ichiro Morioka, Kunling Shen, George A. Syrogiannopoulos, Saul N. Faust, Elena Bozzola

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

11 Citaten (Scopus)

Originele taal-2	Engels
Artikelnummer	981741
Pagina's (van-tot)	981741
Tijdschrift	Frontiers in Pediatrics
Volume	10
DOI's	https://doi.org/10.3389/fped.2022.981741
Status	Gepubliceerd - 9 aug. 2022
Extern gepubliceerd	Ja

Toegang tot document

10.3389/fped.2022.981741

Citeer dit

@article{76f68bf4e020446789b08fb6546d22be,

title = "The assessment of future RSV immunizations: How to protect all infants?",

keywords = "infant and child health, infant hospitalization, infant immunization, infant mortality, monoclonal antibody, respiratory disease, respiratory syncytial virus (RSV), RSV-acute lower respiratory illness",

author = "Louis Bont and {Weil Olivier}, Catherine and Egbert Herting and Susanna Esposito and {Navarro Alonso}, {Jose Antonio} and Federico Lega and Silke Mader and Ichiro Morioka and Kunling Shen and Syrogiannopoulos, {George A.} and Faust, {Saul N.} and Elena Bozzola",

note = "Funding Information: Sanofi and AstraZeneca facilitated and financially supported the RSV Experts Group Event, remuneration to some of the experts was agreed for the time spent for the meeting but the authors were not paid for writing the publication. Funding for the publication fees was provided by Sanofi and AstraZeneca. Hyderus CYF—was paid by Sanofi and AstraZeneca for the expert meeting organization, medical writing, and editorial support. ",

year = "2022",

month = aug,

day = "9",

doi = "10.3389/fped.2022.981741",

language = "English",

volume = "10",

pages = "981741",

journal = "Frontiers in Pediatrics",

issn = "2296-2360",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - The assessment of future RSV immunizations

T2 - How to protect all infants?

AU - Bont, Louis

AU - Weil Olivier, Catherine

AU - Herting, Egbert

AU - Esposito, Susanna

AU - Navarro Alonso, Jose Antonio

AU - Lega, Federico

AU - Mader, Silke

AU - Morioka, Ichiro

AU - Shen, Kunling

AU - Syrogiannopoulos, George A.

AU - Faust, Saul N.

AU - Bozzola, Elena

N1 - Funding Information: Sanofi and AstraZeneca facilitated and financially supported the RSV Experts Group Event, remuneration to some of the experts was agreed for the time spent for the meeting but the authors were not paid for writing the publication. Funding for the publication fees was provided by Sanofi and AstraZeneca. Hyderus CYF—was paid by Sanofi and AstraZeneca for the expert meeting organization, medical writing, and editorial support.

PY - 2022/8/9

Y1 - 2022/8/9

KW - infant and child health

KW - infant hospitalization

KW - infant immunization

KW - infant mortality

KW - monoclonal antibody

KW - respiratory disease

KW - respiratory syncytial virus (RSV)

KW - RSV-acute lower respiratory illness

UR - http://www.scopus.com/inward/record.url?scp=85136906320&partnerID=8YFLogxK

U2 - 10.3389/fped.2022.981741

DO - 10.3389/fped.2022.981741

M3 - Article

C2 - 36016878

AN - SCOPUS:85136906320

SN - 2296-2360

VL - 10

SP - 981741

JO - Frontiers in Pediatrics

JF - Frontiers in Pediatrics

M1 - 981741

ER -